FDA
EMA
MHRA
PMDA
Health Canada

Phase I
Phase II
Phase III
Readouts
Enrollment Signals

Pipeline Tracking
Company Moves
Asset Intelligence
Landscape Reports

Markets

Pricing
Access
Commercial
Launch Tracking

M&A Watch

Licensing
Acquisitions
Partnerships
Capital Raises

Strategy Catalysts Pricing

Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Company

Pricing
Partner with us
Subscribe
Contact
Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Stroke Rehabilitation

Therapeutic area intelligence for Stroke Rehabilitation with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 1

Companies

pharma companies in neurology →

Assets

Neuron →

Recent signals(2)

ClinicalAugust 8, 2026

Study on BCI for Upper Extremity Recovery in Chronic Stroke Patients

A study is investigating the efficacy of a closed-loop brain-computer interface combined with functional electrical stimulation and virtual reality for hemiparetic upper extremity recovery in chronic stroke patients.

CompetitiveJune 22, 2026

Study on Baiobit® Sensor Reliability for Gait Assessment in Stroke Survivors

A study evaluating the reliability of the Baiobit® inertial sensor for gait assessment in stroke survivors is underway.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.